WHWK
Whitehawk Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.20
+2.94%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- -$0.27
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- -$0.20
- EPS estimate
- -$0.30
- Revenue actual
- —
- Revenue estimate
- -$350.0K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +30.5%
- Revenue beats (12Q)
- —
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $9.50
- PT range
- $9.00 – $10
- Analysts
- 2
2 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | -$0.30 | -$0.20 | Beat 32.37% | — |
| May 7, 2026 | -$0.36 | -$0.32 | Beat 11.11% | — |
| Mar 12, 2026 | -$0.48 | -$0.34 | Beat 29.55% | — |
| Nov 6, 2025 | -$0.51 | -$0.26 | Beat 49.02% | — |
| Aug 7, 2025 | $0.49 | -$0.76 | Miss -255.10% | — |
| May 8, 2025 | -$0.46 | -$0.36 | Beat 21.74% | $7.1M |
| Mar 18, 2025 | -$0.22 | -$0.67 | Miss -204.55% | $7.2M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026